Q&A

Should we welcome the coming wave of anti-obesity drugs, and what’s at stake in the argument over the 14-day limit on embryo research?

Our final Q&A episode of the year tackles two medical ethics questions in the news recently. The first is Wegovy, the ground-breaking anti-obesity drug which has been a controversial sensation in the United States. It is now available (in very limited supply) on the NHS here in the UK, but only for those with quite serious obesity with BMIs of 35 or higher. Should Christians hail this a brilliant medical advance tackling a serious public health issue, or a worrying example of big pharma trying to medicate away our self-control? Next, we discuss a new push by some scientists to soften the ground ahead of a campaign to extend the current 14-day limit on human embryo research. Why do researchers want to keep embryos alive in petri dishes for longer, and will it actually benefit any of us in the end really?

Listen to other episodes of Matters of Life and Death or find us on Spotify, Apple Podcasts, Pocket Casts, Google Podcasts, Podcast Addict, Castbox or whatever app you use to subscribe and receive new episodes sent straight to your device.

Tags
Most read posts
What can we learn from how the early church lived out their faith during their own pandemics?
How are young people different to those who came before, and what can we learn from them?
Navigating the transitions of later life
This Bill is the wrong approach - there is a better way to give individuals and their families dignity at the end of life
Living faithfully as we approach retirement, dependence, dementia and death
Recent posts
Expressive individualism meets simulated personhood
These verses act for many pro-life Christians as the cornerstone of their theology
There's been a rash of reports that people who spend too long with ChatGPT are ending up mentally ill, or even suicidal
The ethics of why some religious groups (let alone swathes of Americans) cut their sons' foreskins off are surprisingly complicated
Theological and medical responses to assisted dying